AI Consolidation, Biotech Opportunities, and World Models with Sarah and Elad
In this episode of No Priors, Sarah and Elad unpack the current state of the AI market - whether it’s consolidating, what’s enabling or blocking key mergers, and where the most promising untapped opportunities lie, particularly in biotech. They also explore the rise of world models and how AI’s novel methods for…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from No Priors: Artificial Intelligence | Technology | Startups
See all episodes →
43%From Restoring Sight to Reimagining the Brain, with Max Hodak
35%Redefining Chip Architecture with Arm CEO Rene Haas
33%Rethinking Legacy Data Infrastructure with Eon Co-Founders Ofir Ehrlich and Gonen Stein
Similar episodes from other shows
More like No Priors: Artificial Intelligence | Technology | Startups →
20VC: In AI Who Wins? Startups or Incumbents? What Happens to Wealth Inequality? Why Will $10BN+ Companies Only Have 10 People | Why Defensibility in Startups is BS & Speed is Everything? Why Large Groups Worsen Decision-Making with Sarah Guo
[State of AI Startups] Memory/Learning, RL Envs & DBT-Fivetran — Sarah Catanzaro, Amplify
Elad Gil: How to Spot a Billion-Dollar Startup Before the Rest of the World
AI Revolution: Disruption, Alignment, and Opportunity
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.